共 18 条
- [5] Scoping Review of Interventions Associated with Cost Avoidance Able to Be Performed in the Intensive Care Unit and Emergency Department [J]. PHARMACOTHERAPY, 2019, 39 (03): : 215 - 231
- [7] Position Paper on Critical Care Pharmacy Services: 2020 Update [J]. CRITICAL CARE MEDICINE, 2020, 48 (09) : E813 - E834
- [8] Pharmacist participation on physician rounds and adverse drug events in the intensive care unit [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (03): : 267 - 270
- [10] MacLaren Robert, 2021, Crit Care Explor, V3, pe0323, DOI 10.1097/CCE.0000000000000323